Thomson Reuters recently published an updated Q&A guide to Life Sciences regulation and commercialisation in Ireland, authored by Colin Kavanagh, Richard Ryan and Olivia Mullooly.

The Life Sciences regulation Q&A provides a high-level overview of key practical issues, including life sciences clinical trials, manufacturing, marketing, abridged procedure, pharmacovigilance, data privacy, packaging and labelling, biological medicines, medical devices, healthcare IT, combination products, borderlines, and natural health products.

The Life Sciences commercialisation Q&A provides a high-level overview of key practical issues, including the life sciences sector, pricing and state funding, distribution and sale, importing, advertising, patents, trade marks, competition law, and product liability.

Read more below.

1. Life Sciences Commercialisation in Ireland Overview.
2. Life Sciences Regulation in Ireland Overview.